PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT)
Historical Holders from Q3 2024 to Q4 2025
-
Type / Class
-
Equity / Ordinary shares, no par value per share
-
Symbol
-
PPBT on Nasdaq
-
Shares outstanding
-
2,006,543,493
-
Price per share
-
$0.66
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
132,492
-
Total reported value
-
$75,782
-
% of total 13F portfolios
-
0%
-
Share change
-
+70,524
-
Value change
-
+$9,481
-
Number of holders
-
11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
INTRACOASTAL CAPITAL, LLC
|
10%
|
0%
|
$115,100,512
|
+$34,923,545
|
200,453,695
|
+44%
|
Mitchell P. Kopin
|
30 Sep 2025
|
|
Lincoln Alternative Strategies LLC
|
9.9%
|
|
$1,288,650
|
|
605,000
|
|
Lincoln Alternative Strategies LLC
|
04 Sep 2025
|
|
Orca Capital AG
|
4.9%
|
|
$652,619
|
|
306,394
|
|
Orca Capital AG
|
04 Sep 2025
|
As of 30 Sep 2025,
PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) has
11
institutional shareholders
filing 13F forms.
They hold
132,492 shares.
of 2,006,543,493
outstanding shares (0.01%)
.
Institutional Holders of PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q4
|
2,836
|
$1,865
|
-$6,456
|
|
|
$0.66
|
1
|
|
2025 Q3
|
132,492
|
$75,782
|
+$9,481
|
|
|
$0.57
|
11
|
|
2025 Q2
|
56,968
|
$133,604
|
+$12,851
|
|
|
$2.34
|
10
|
|
2025 Q1
|
50,573
|
$134,236
|
-$128,880
|
|
|
$2.66
|
7
|
|
2024 Q4
|
80,346
|
$376,821
|
-$567,896
|
|
|
$4.69
|
12
|
|
2024 Q3
|
170,369
|
$945,992
|
+$925,596
|
|
|
$5.56
|
9
|